These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11396174)

  • 1. Influence of beta-adrenergic antagonists, H1-receptor blockers, analgesics, diuretics, and quinolone antibiotics on the cellular accumulation of the anticancer drug, daunorubicin: P-glycoprotein modulation.
    Ibrahim S; Peggins J; Knapton A; Licht T; Aszalos A
    Anticancer Res; 2001; 21(2A):847-56. PubMed ID: 11396174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of antipsychotic, antiemetic, and Ca(2+) channel blocker drugs on the cellular accumulation of the anticancer drug daunorubicin: P-glycoprotein modulation.
    Ibrahim S; Peggins J; Knapton A; Licht T; Aszalos A
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1276-83. PubMed ID: 11082465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of P-glycoprotein transport function and reversion of MDR1 multidrug resistance by cnidiadin.
    Barthomeuf C; Grassi J; Demeule M; Fournier C; Boivin D; Béliveau R
    Cancer Chemother Pharmacol; 2005 Aug; 56(2):173-81. PubMed ID: 15824923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
    Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exposure to antiepileptic drugs does not alter the functionality of P-glycoprotein in brain capillary endothelial and kidney cell lines.
    Ambroziak K; Kuteykin-Teplyakov K; Luna-Tórtos C; Al-Falah M; Fedrowitz M; Löscher W
    Eur J Pharmacol; 2010 Feb; 628(1-3):57-66. PubMed ID: 19958760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of P-glycoprotein-mediated multidrug resistance by acceleration of passive drug permeation across the plasma membrane.
    Regev R; Katzir H; Yeheskely-Hayon D; Eytan GD
    FEBS J; 2007 Dec; 274(23):6204-14. PubMed ID: 17986257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells.
    Sachs-Barrable K; Thamboo A; Lee SD; Wasan KM
    J Pharm Pharm Sci; 2007; 10(3):319-31. PubMed ID: 17727795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen.
    Lee JS; Paull K; Alvarez M; Hose C; Monks A; Grever M; Fojo AT; Bates SE
    Mol Pharmacol; 1994 Oct; 46(4):627-38. PubMed ID: 7969041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of cytochrome P450 3A inhibitors with P-glycoprotein.
    Yasuda K; Lan LB; Sanglard D; Furuya K; Schuetz JD; Schuetz EG
    J Pharmacol Exp Ther; 2002 Oct; 303(1):323-32. PubMed ID: 12235267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of hypotonic and hypoionic media on drug pumping by P-glycoprotein expressed in epithelial and nonepithelial cell lines.
    Ambasch K; Cabantchik ZI; Slotki IN
    J Cell Physiol; 1995 Jul; 164(1):117-22. PubMed ID: 7790383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro flow cytometry method to quantitatively assess inhibitors of P-glycoprotein.
    Wang EJ; Casciano CN; Clement RP; Johnson WW
    Drug Metab Dispos; 2000 May; 28(5):522-8. PubMed ID: 10772630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conferone from Ferula schtschurowskiana enhances vinblastine cytotoxicity in MDCK-MDR1 cells by competitively inhibiting P-glycoprotein transport.
    Barthomeuf C; Demeule M; Grassi J; Saidkhodjaev A; Beliveau R
    Planta Med; 2006 Jun; 72(7):634-9. PubMed ID: 16739070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of P-glycoprotein-mediated multidrug resistance by protopanaxatriol ginsenosides from Korean red ginseng.
    Choi CH; Kang G; Min YD
    Planta Med; 2003 Mar; 69(3):235-40. PubMed ID: 12677527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposome composition is important for retention of liposomal rhodamine in P-glycoprotein-overexpressing cancer cells.
    Kang DI; Kang HK; Gwak HS; Han HK; Lim SJ
    Drug Deliv; 2009 Jul; 16(5):261-7. PubMed ID: 19538007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
    Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A
    Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid induction of P-glycoprotein expression by high permeability compounds in colonic cells in vitro: a possible source of transporter mediated drug interactions?
    Collett A; Tanianis-Hughes J; Warhurst G
    Biochem Pharmacol; 2004 Aug; 68(4):783-90. PubMed ID: 15276086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversing drug resistance in the ovarian carcinoma cell line SKOV3/mdr1 in vitro by antisense oligodeoxynucleotides.
    Pan L; Tong Y; Jin Y; Zhou S; Zhang Y; Yang X; Mao N
    Chin Med J (Engl); 2001 Sep; 114(9):929-32. PubMed ID: 11780384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1.
    Chen YB; Yan ML; Gong JP; Xia RP; Liu LX; Li N; Lu SC; Zhang JG; Zeng DB; Xie JG; Yang JY; Yan LN
    Chin Med J (Engl); 2007 Apr; 120(8):703-7. PubMed ID: 17517188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity.
    Taub ME; Podila L; Ely D; Almeida I
    Drug Metab Dispos; 2005 Nov; 33(11):1679-87. PubMed ID: 16093365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative and functional assay of MDR1/P170-mediated MDR in ascites cells of patients with ovarian cancer.
    Krasznai ZT; Friedländer E; Nagy A; Szabó G; Vereb G; Goda K; Hernádi Z
    Anticancer Res; 2005; 25(2A):1187-92. PubMed ID: 15868961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.